EC Number |
Substrates |
Organism |
Products |
Reversibility |
---|
3.4.23.38 | 4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-(gamma-aminobutyryl)-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid + H2O |
- |
Plasmodium falciparum |
4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Met-Phe + Leu-Ser-Phe-Pro-(gamma-aminobutyryl)-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid |
- |
? |
3.4.23.38 | 4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Nle-Phe-Leu-Ser-Phe-Pro-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid + H2O |
- |
Plasmodium falciparum |
4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Nle-Phe + Leu-Ser-Phe-Pro-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid |
- |
? |
3.4.23.38 | 4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Met-Phe + Leu-Ser-Phe-Pro-(gamma-aminobutyryl)-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | 4-[[4'-(dimethylamino)phenyl]azo]-benzoyl-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-(gamma-aminobutyryl)-5-[(2'-aminoethyl)-amino]naphthalenesulfonic acid + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | EDANS-CO-CH2-CH2-CO-Ala-Leu-Glu-Arg-Met-Phe-Leu-Ser-Phe-Pro-Dap-(DABCYL)-OH + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | Hemoglobin + H2O |
- |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | Hemoglobin + H2O |
enzyme is involved in initial steps of Plasmodium hemoglobin degradation |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | Hemoglobin + H2O |
the enzyme initiates the hemoglobin degradation pathway in Plasmodium |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | Hemoglobin + H2O |
during the infection of erythrocytes by the human malaria parasite Plasmodium falciparum, up to 80% of the host cell hemoglobin is degraded to provide amino acids for parasite nutrition. Plasmepsin I and plasmepsin II are believed to be responsible for initiating the catabolic process |
Plasmodium falciparum |
? |
- |
? |
3.4.23.38 | hemoglobin alpha-chain + H2O |
- |
Plasmodium falciparum |
? |
- |
? |